Aiden Y. Lee

Array ( [id] => 6248994 [patent_doc_number] => 20100137292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'Pharmaceutical formulations of meloxicam' [patent_app_type] => utility [patent_app_number] => 12/591753 [patent_app_country] => US [patent_app_date] => 2009-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2229 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137292.pdf [firstpage_image] =>[orig_patent_app_number] => 12591753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8928467 [patent_doc_number] => 20130184227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-18 [patent_title] => 'Cytochrome P450 2C9 Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/628194 [patent_app_country] => US [patent_app_date] => 2009-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7172 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12628194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6266875 [patent_doc_number] => 20100298305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'TIZANIDINE FOR THE TREATMENT OF POST-TRAUMATIC STRESS DISORDER AND NIGHTMARES' [patent_app_type] => utility [patent_app_number] => 12/626500 [patent_app_country] => US [patent_app_date] => 2009-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18327 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298305.pdf [firstpage_image] =>[orig_patent_app_number] => 12626500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6638341 [patent_doc_number] => 20100173936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'Compositions comprising renin-angiotensin aldosterone system inhibitors and lipoic acid compounds, and the use thereof for the treatment of renin-angiotensin aldosterone system-related disorders' [patent_app_type] => utility [patent_app_number] => 12/591560 [patent_app_country] => US [patent_app_date] => 2009-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17556 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173936.pdf [firstpage_image] =>[orig_patent_app_number] => 12591560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6583039 [patent_doc_number] => 20100291181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'THERAPEUTIC DEVICES FOR PATTERNED CELL GROWTH' [patent_app_type] => utility [patent_app_number] => 12/618221 [patent_app_country] => US [patent_app_date] => 2009-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16418 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291181.pdf [firstpage_image] =>[orig_patent_app_number] => 12618221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6412489 [patent_doc_number] => 20100166751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'CANCER THERAPY USING WHOLE GLUCAN PARTICLES AND ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/615040 [patent_app_country] => US [patent_app_date] => 2009-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 14589 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166751.pdf [firstpage_image] =>[orig_patent_app_number] => 12615040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501911 [patent_doc_number] => 20110263656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'Pirfenidone Treatment for Patients with Atypical Liver Function' [patent_app_type] => utility [patent_app_number] => 13/128569 [patent_app_country] => US [patent_app_date] => 2009-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10281 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263656.pdf [firstpage_image] =>[orig_patent_app_number] => 13128569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6479705 [patent_doc_number] => 20100041751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'Method to Reduce Oxidative Damage and Improve Mitochondrial Efficiency' [patent_app_type] => utility [patent_app_number] => 12/604668 [patent_app_country] => US [patent_app_date] => 2009-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11532 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041751.pdf [firstpage_image] =>[orig_patent_app_number] => 12604668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6454334 [patent_doc_number] => 20100105643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'Ophthalmic composition' [patent_app_type] => utility [patent_app_number] => 12/589341 [patent_app_country] => US [patent_app_date] => 2009-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3935 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105643.pdf [firstpage_image] =>[orig_patent_app_number] => 12589341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6245630 [patent_doc_number] => 20100135999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'QUINOLINE-CARBOXAMIDE DERIVATIVES AS P2Y12 ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/573551 [patent_app_country] => US [patent_app_date] => 2009-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 124021 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20100135999.pdf [firstpage_image] =>[orig_patent_app_number] => 12573551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11275996 [patent_doc_number] => 09492468 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-15 [patent_title] => 'Methods and compositions for treatment of acute heart failure' [patent_app_type] => utility [patent_app_number] => 12/573043 [patent_app_country] => US [patent_app_date] => 2009-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 20478 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12573043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6360186 [patent_doc_number] => 20100087481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'ORAL PHARMACEUTICAL FORMULATIONS FOR ANTIDIABETIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/572803 [patent_app_country] => US [patent_app_date] => 2009-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12093 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20100087481.pdf [firstpage_image] =>[orig_patent_app_number] => 12572803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6593180 [patent_doc_number] => 20100130608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'COMPOSITIONS AND METHODS FOR REDUCING TRIGLYCERIDE LEVELS' [patent_app_type] => utility [patent_app_number] => 12/572263 [patent_app_country] => US [patent_app_date] => 2009-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14706 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130608.pdf [firstpage_image] =>[orig_patent_app_number] => 12572263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8290477 [patent_doc_number] => 20120178806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'PHARMACEUTICAL FORMULATIONS COMPRISING 9-CIS-RETINYL ESTERS IN A LIPID VEHICLE' [patent_app_type] => utility [patent_app_number] => 13/496113 [patent_app_country] => US [patent_app_date] => 2009-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 9514 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13496113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6645308 [patent_doc_number] => 20100227920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'Aldehyde dehydrogenase inhibitors as novel depigmenting agents' [patent_app_type] => utility [patent_app_number] => 12/587010 [patent_app_country] => US [patent_app_date] => 2009-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 9514 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227920.pdf [firstpage_image] =>[orig_patent_app_number] => 12587010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6445364 [patent_doc_number] => 20100144711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION' [patent_app_type] => utility [patent_app_number] => 12/568342 [patent_app_country] => US [patent_app_date] => 2009-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8199 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144711.pdf [firstpage_image] =>[orig_patent_app_number] => 12568342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7682252 [patent_doc_number] => 20100022556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'Therapeutic combinations comprising a long acting dihydropyridine calcium-channel blocker and a statin' [patent_app_type] => utility [patent_app_number] => 12/567865 [patent_app_country] => US [patent_app_date] => 2009-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4334 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022556.pdf [firstpage_image] =>[orig_patent_app_number] => 12567865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6446942 [patent_doc_number] => 20100144807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR MODIFIED RELEASE' [patent_app_type] => utility [patent_app_number] => 12/568313 [patent_app_country] => US [patent_app_date] => 2009-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8521 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144807.pdf [firstpage_image] =>[orig_patent_app_number] => 12568313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6446942 [patent_doc_number] => 20100144807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR MODIFIED RELEASE' [patent_app_type] => utility [patent_app_number] => 12/568313 [patent_app_country] => US [patent_app_date] => 2009-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8521 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144807.pdf [firstpage_image] =>[orig_patent_app_number] => 12568313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7784749 [patent_doc_number] => 20120046305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/120891 [patent_app_country] => US [patent_app_date] => 2009-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 190 [patent_figures_cnt] => 190 [patent_no_of_words] => 39231 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20120046305.pdf [firstpage_image] =>[orig_patent_app_number] => 13120891 [rel_patent_id] =>[rel_patent_doc_number] =>)